Harvard Medical School9h
Creating the World’s First CRISPR Medicine, for Sickle Cell Disease
In December 2023, through the development efforts of CRISPR Therapeutics and Vertex Pharmaceuticals, their decades-long ...
The Stocks and ETFs Driving Trump’s Tariff Target Markets
Conversations about Trump’s tariffs, despite two of them being placed on hold for now, continue to dominate market discussions. Although it could be different this time, historically these ...